Construction works begin on WuXi facility

The new €325 million state-of-the-art WuXi Biologics facility has begun to take structural form as steel erection begins on the company’s 52-acre campus site in Dundalk. Work is on schedule for the new contract manufacturing biologics facility which, at 48,000 square metres in size, is set to become the world’s largest single-use biologics manufacturing facility.
Planning approval for the facility was confirmed in mid-January. Since then some 200,000 tonnes of earth have been moved and relocated within the site during site-development works while 2,900 cubic metres of concrete poured for foundations. In all, over 5,000 tonnes of steel sourced from an Irish supplier has arrived on site to enable steel-works get underway.
“The project is truly moving at ‘WuXi speed’ and we are delighted with progress to date”, said WuXi Biologics Ireland Site Head and VP Manufacturing Brendan McGrath. “Cladding work will commence at the end of July and we are on target to have all of the buildings weather tight by January. This will enable us to move ahead with the installation of the processing plant and equipment to bring us into full commercial production on schedule by 2022.”
The rapidly advancing schedule will see the number of construction workers on site increase from 120 at present to 500 by year end. Peak construction employment for the project will reach 2,000.

This entry was posted in Articles. Bookmark the permalink.

Comments are closed.